Daniel Billen

Daniel Billen appears in our data through filings on Aurinia Pharmaceuticals Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 18 May 2023 to 21 May 2024.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 23 May 2024 came the latest disclosure, an option exercise in Aurinia Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.